Anna Djos

Mrs. Anna Djos


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2011 in BMC Cancer
Verified
Journal Article
Open access
PDF file
HCHelena Carén
Helena Carén
ADAnna Djos
Anna Djos
MNMaria Nethander
Maria Nethander
RSRose-Marie Sjöberg
Rose-Marie Sjöberg
PKPer Kogner
Per Kogner
TMTommy Martinsson
Tommy Martinsson
Epigenetic mechanisms such as DNA methylation and histone modifications are important regulators of gene expression and are frequently involved in silencing tumor suppressor genes.

13 June 2012 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
ADAnna Djos
Anna Djos
TMTommy Martinsson
Tommy Martinsson
PKPer Kogner
Per Kogner
HCHelena Carén
Helena Carén
Hypermethylation of promotor CpG islands is a common mechanism that inactivates tumor suppressor genes in cancer. Genes belonging to the RASSF gene family have frequently been reported as epigenetically silenced by promotor methylation in human cancers. Two members of this gene family, RASSF1A and RASSF5A have been reported as methylated in neuroblastoma. Data from our previously performed genome-wide DNA methylation array analysis indicated that other members of the RASSF gene family are targeted by DNA methylation in neuroblastoma.

2 October 2013 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
ADAnna Djos
Anna Djos
SFSusanne Fransson
Susanne Fransson
PKPer Kogner
Per Kogner
TMTommy Martinsson
Tommy Martinsson
Background: Chromosomal instability is a hallmark of human cancer caused by errors in mitotic control and chromosome segregation. STAG2 encodes a subunit of the cohesion complex that participates in mitotic chromatid separation and was recently found to show low expression and inactivating mutations in Ewing’s sarcoma, melanoma and glioblastoma. In the childhood tumor neuroblastoma (NB) segmental chromosomal alterations are associated with poor prognosis whereas tumors displaying whole chromosome gains and losses have a much better prognosis. Method: As the genetic contribution to aneuploidy is unknown in NB, we investigated the presence of STAG2 mutations through sequence analysis of all 33 coding exons in 37 primary NB tumors. Results and conclusion: As no STAG2 mutation was detected in this study, we conclude that inactivating mutation of STAG2 is not likely causative to neuroblastoma aneuploidy.